76 related articles for article (PubMed ID: 2578002)
1. Oncogene detection at the single cell level.
Kumar R; Barbacid M
Oncogene; 1988 Dec; 3(6):647-51. PubMed ID: 2578002
[TBL] [Abstract][Full Text] [Related]
2. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.
Kumar R; Dunn LL
Oncogene Res; 1989; 4(3):235-41. PubMed ID: 2567980
[TBL] [Abstract][Full Text] [Related]
3. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
Behn M; Qun S; Pankow W; Havemann K; Schuermann M
Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
5. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
6. Optimization of restriction fragment length polymorphism and single strand conformation polymorphism analysis for the detection of point mutations of ras oncogenes in paraffin-embedded tissues.
Weise B; Ghebremedhin E; Zschunke F; Radzun HJ
Gen Diagn Pathol; 1996 Jun; 142(1):45-52. PubMed ID: 8793486
[TBL] [Abstract][Full Text] [Related]
7. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
8. Use of PCR-PIRA for screening of a point mutation at codon 12 in K-ras oncogene obtained from paraffin embedded tissue sections.
Chewawiwat N; Lulitanond V; Nimmanahaeminda K; Thamprasert K; Nicomrat D; Ponglikitmongkol M
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():329-32. PubMed ID: 8629136
[TBL] [Abstract][Full Text] [Related]
9. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].
Fukayama N; Sugano K; Kyogoku A; Nose H; Kondou H; Ohkura H
Rinsho Byori; 1993 Sep; 41(9):1017-23. PubMed ID: 8254964
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
11. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
Knowles MA; Williamson M
Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
[TBL] [Abstract][Full Text] [Related]
12. Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes.
Wabuyele MB; Farquar H; Stryjewski W; Hammer RP; Soper SA; Cheng YW; Barany F
J Am Chem Soc; 2003 Jun; 125(23):6937-45. PubMed ID: 12783546
[TBL] [Abstract][Full Text] [Related]
13. Instability at the H-ras minisatellite is associated with the spontaneous abortion of the embryo.
Kiaris H; Ergazaki M; Spandidos DA
Biochem Biophys Res Commun; 1995 Sep; 214(3):788-92. PubMed ID: 7575545
[TBL] [Abstract][Full Text] [Related]
14. Facilitated detection of oncogene mutations from exfoliated tissue material by a PNA-mediated 'enriched PCR' protocol.
Behn M; Thiede C; Neubauer A; Pankow W; Schuermann M
J Pathol; 2000 Jan; 190(1):69-75. PubMed ID: 10640994
[TBL] [Abstract][Full Text] [Related]
15. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
16. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay.
Santiago FS; Todd AV; Hawkins NJ; Ward RL
Mol Cell Probes; 1997 Feb; 11(1):33-8. PubMed ID: 9076712
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
Cerutti P; Hussain P; Pourzand C; Aguilar F
Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
[TBL] [Abstract][Full Text] [Related]
18. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
Weismanová E; Kalúz S; Skorvaga M
Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
[TBL] [Abstract][Full Text] [Related]
19. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia.
Jacobson DR; Mills NE
Oncogene; 1994 Feb; 9(2):553-63. PubMed ID: 8290266
[TBL] [Abstract][Full Text] [Related]
20. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
Detorakis ET; Zafiropoulos A; Arvanitis DA; Spandidos DA
Eye (Lond); 2005 Feb; 19(2):210-4. PubMed ID: 15232598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
